Patents by Inventor KELLY A. HARRADINE

KELLY A. HARRADINE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gene Expression Markers for Prediction of Response to Platinum-Based Chemotherapy Drugs
    Publication number: 20120046186
    Abstract: The present invention provides methods for predicting a likelihood that a patient with cancer will exhibit a positive response to a treatment with a platinum-based chemotherapy drug. The methods generally involve determining an expression level of a gene product that correlates with responsiveness to treatment with a platinum-based chemotherapy drug. In an embodiment of the invention, the platinum-based chemotherapy drug is oxaliplatin, and the cancer is colorectal cancer.
    Type: Application
    Filed: August 16, 2011
    Publication date: February 23, 2012
    Inventors: ROBERT J. PELHAM, KELLY A. HARRADINE, JOFFRE B. BAKER